Anthera Pharmaceuticals, Inc.
ANTH · OTC
12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27 | -$56 | -$35 | -$30 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | -$4 | $0 |
| Stock-Based Comp. | $4 | $7 | $4 | $2 |
| Change in WC | -$5 | $1 | $0 | $0 |
| Other Non-Cash | -$10 | -$2 | $4 | $1 |
| Operating Cash Flow | -$37 | -$49 | -$31 | -$26 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $10 |
| Investing Cash Flow | $0 | -$1 | -$0 | $10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$18 |
| Stock Issued | $18 | $7 | $75 | $10 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $40 | $0 | $0 |
| Financing Cash Flow | $18 | $24 | $75 | -$8 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$19 | -$26 | $44 | -$23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | $47 | $3 | $26 |
| End Cash | $2 | $21 | $47 | $3 |
| Free Cash Flow | -$37 | -$50 | -$31 | -$26 |